Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Brain mets management in HER2+ and triple negative breast cancer

HER2 targeting agents for treatment of HER2+ breast cancer with brain mets

Date

08 May 2021

Session

Brain mets management in HER2+ and triple negative breast cancer

Presenters

Volkmar Mueller

Authors

V. Mueller

Author affiliations

  • UKE Universitätsklinikum Hamburg-Eppendorf KMTZ, 20246 - Hamburg/DE
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings